702 Results

People

  1. Motzer
    Motzer
  2. Livingston
    Livingston
  3. Norton
    Norton
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Krown
    Krown
  7. Sepkowitz
    Sepkowitz
  8. O'Reilly
    O'Reilly
  9. Panageas
    Panageas
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)
  7. Epidemiology and Biostatistics (73)
  8. GSK Faculty (73)
  9. Division of Subspecialty Medicine (65)
  10. Gastrointestinal Oncology Service (64)
  1. "fever"
Formats
  1. Journal Article (657)
  2. Review (23)
  3. Conference Paper (6)
  4. Research Letter (6)
  5. Guidelines (5)
  6. Editorial (4)
  7. Correspondence (1)
Groups
  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)

More Groups

People
  1. Robert Motzer (24)
  2. Larry Norton (20)
  3. Philip Livingston (19)
  4. Carol Aghajanian (17)
  5. Clifford Hudis (17)
  6. Kent Sepkowitz (17)

More People

Years
  1. 2025 (21)
  2. 2024 (42)
  3. 2023 (40)
  4. 2022 (22)
  5. 2021 (25)
  6. 2020 (44)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Clinical Cancer Research (33)
  3. Blood (22)
  4. Lancet Oncology (22)
  5. Cancer (21)
  6. New England Journal of Medicine (18)

More Publications

Publishers
  1. Elsevier Inc. (107)
  2. American Society of Clinical Oncology (70)
  3. Elsevier Science, Inc. (55)
  4. Springer (53)
  5. Nature Publishing Group (40)
  6. Wiley Blackwell (38)

More Publishers

Results (702)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant systemic therapy (NAST) in patients with melanoma: Surgical considerations by the International Neoadjuvant Melanoma Consortium (INMC)
    Guidelines

    van Akkooi, A. C. J.; Hieken, T. J.; Burton, E. M.; Ariyan, C.; Ascierto, P. A.; Asero, S. V. M. A.; Blank, C. U.; Block, M. S.; Boland, G. M.; Caraco, C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Crimean-Congo haemorrhagic fever during the COVID-19 pandemic in Africa: Efforts, recommendations and challenges at hand
    Editorial

    Greene, L.; Uwishema, O.; Nicholas, A.; Kapoor, A.; Berjaoui, C.; Adamolekun, E.; Khoury, C.; Mohammed, F. E. A.; Onyeaka, H.
    African Journal of Emergency Medicine (2022)

    Fulltext@MSK | Save
  • Variation in clinical practice and attitudes on antibacterial management of fever and neutropenia in patients with hematologic malignancy: A survey of cancer centers across the United States
    Journal Article

    Barreto, J. N.; Aitken, S. L.; Krantz, E. M.; Nagel, J. L.; Dadwal, S. S.; Seo, S. K.; Liu, C.
    Open Forum Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: Survival update and new extension cohort data
    Journal Article

    Sehn, L. H.; Hertzberg, M.; Opat, S.; Herrera, A. F.; Assouline, S.; Flowers, C. R.; Kim, T. M.; McMillan, A.; Ozcan, M.; Safar, V.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Bacteremia in febrile, non-neutropenic, and well-appearing children with cancer
    Journal Article

    Beauchemin, M.; Marshall, A. F.; Ricci, A. M.; Lopez, I. D.; Yao, Y.; Lee, A.; Jin, Z.; Sulis, M. L.
    Journal of Pediatric Hematology/Oncology (2022)

    Fulltext@MSK | Save
  • Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
    Journal Article

    Yarchoan, M.; Cope, L.; Ruggieri, A. N.; Anders, R. A.; Noonan, A. M.; Goff, L. W.; Goyal, L.; Lacy, J.; Li, D.; Patel, A. K.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • Temozolomide in grade 3 gastroenteropancreatic neuroendocrine neoplasms: A multicenter retrospective review
    Journal Article

    Chan, D. L.; Bergsland, E. K.; Chan, J. A.; Gadgil, R.; Halfdanarson, T. R.; Hornbacker, K.; Kelly, V.; Kunz, P. L.; McGarrah, P. W.; Raj, N. P.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Feasibility of combining the phosphatidylinositol 3-kinase inhibitor copanlisib with rituximab-based immunochemotherapy in patients with relapsed indolent B-cell lymphoma
    Journal Article

    Matasar, M. J.; Dreyling, M.; Leppä, S.; Santoro, A.; Pedersen, M.; Buvaylo, V.; Fletcher, M.; Childs, B. H.; Zinzani, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Association of varying clinical manifestations and positive anti-SARS-CoV-2 IgG antibodies: A cross-sectional observational study
    Journal Article

    Silverberg, J. I.; Zyskind, I.; Naiditch, H.; Zimmerman, J.; Glatt, A. E.; Pinter, A.; Theel, E. S.; Joyner, M. J.; Hill, D. A.; Lieberman, M. R.; more...
    Journal of Allergy and Clinical Immunology: In Practice (2021)

    Fulltext@MSK | Save
  • Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): A multicentre, open-label, phase 2a, multiple basket study
    Journal Article

    Javle, M.; Borad, M. J.; Azad, N. S.; Kurzrock, R.; Abou-Alfa, G. K.; George, B.; Hainsworth, J.; Meric-Bernstam, F.; Swanton, C.; Sweeney, C. J.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save